Advertisement

Uro-News

, Volume 23, Issue 2, pp 30–33 | Cite as

Mehr Klarheit bei hypersensitiver Blase

Erste deutsche S2k-Leitlinie zur interstitiellen Zystitis

  • Thomas BschleipferEmail author
Fortbildung
  • 1 Downloads

Bei der hypersensitiven Blase handelt es sich um ein schwerwiegendes Krankheitsbild, das nach wie vor viele Rätsel aufgibt. Um die Diagnostik und Behandlung dieser seltenen Erkrankung zu verbessern, wurde nun erstmalig eine deutschsprachige S2k-Leitlinie zum Thema interstitiellen Zystitis und zum Blasenschmerzsyndrom verfasst.

Literatur

  1. 1.
    S2k-Leitlinie „Diagnostik und Therapie der Interstitiellen Cystitis (IC/BPS)“ der Deutschen Gesellschaft für Urologie (www.awmf.org/leitlinien/detail/ll/043-050.html)
  2. 2.
    Davis NF et al. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014; 174: 30–7CrossRefGoogle Scholar
  3. 3.
    Oemler M et al. Psychosocial aspects of interstitial cystitis. Do biographical factors have a relevant impact on the disease course? Der Urologe, 2006; 45: 728–33CrossRefGoogle Scholar
  4. 4.
    FitzGerald M et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012; 187: 2113–8CrossRefGoogle Scholar
  5. 5.
    Berner MM et al. The german version of the female sexual function index (FSFI-d). Int J Impot Res. 2002; 14: 79–90CrossRefGoogle Scholar
  6. 6.
    Kuo YC et al. Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women. Int J Clin Pract. 2012; 66: 146–51CrossRefGoogle Scholar
  7. 7.
    Störkel S. Interstitielle Zystitis aus der Sicht der Pathologen. In: Interstitielle Zystitis — The State of the Art, Biermann Verlag, Köln, 2002: 43–8Google Scholar
  8. 8.
    Homma Y et al. Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis. J Urol. 2013; 190: 1925–31CrossRefGoogle Scholar
  9. 9.
    Kutlar A et al. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol. 2012; 87: 536–9CrossRefGoogle Scholar
  10. 10.
    Hanno PM et al. Conservative therapy of interstitial cystitis. Semin Urol. 1991; 9: 143–7PubMedGoogle Scholar
  11. 11.
    Jocham D et al. The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients. Urologe A. 2013; 52: 691–702CrossRefGoogle Scholar
  12. 12.
    Bouchelouche K et al. Treatment of interstitial cystitis with montelukast, a leukotriene D(4) receptor antagonist. Urology. 2001; 57 (6 Suppl 1): 118CrossRefGoogle Scholar
  13. 13.
    Fleischmann J. Calcium channel antagonists in the treatment of interstitial cystitis. Urol Clin North Am. 1994; 21: 107–11PubMedGoogle Scholar
  14. 14.
    Homma Y et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol. 2009; 16: 597–615CrossRefGoogle Scholar
  15. 15.
    Hanno PM et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015; 193: 1545–53CrossRefGoogle Scholar
  16. 16.
    Riedl CR et al. Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis. J Endourol. 1998; 12: 269–72CrossRefGoogle Scholar
  17. 17.
    Peters KM et al. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007; 100: 835–9CrossRefGoogle Scholar
  18. 18.
    Lampel, A., Operations Optionen bei refraktärer interstitieller Zystitis. 2014, Schwarzwald-Baar Klinikum Villingen-Schwenningen.Google Scholar
  19. 19.
    Irwin PP et al. Surgical management of interstitial cystitis. Urol Clin North Am. 1994; 21: 145–51PubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.Klinik für Urologie, Andrologie und KinderurologieKlinikum Weiden/Kliniken Nordoberpfalz AGWeiden i. d. Opf.Deutschland

Personalised recommendations